Medtronic plc (ETR: 2M6)
Germany
· Delayed Price · Currency is EUR | Market Cap | 99.75B |
| Revenue (ttm) | 30.49B |
| Net Income (ttm) | 3.96B |
| Shares Out | n/a |
| EPS (ttm) | 3.02 |
| PE Ratio | 25.18 |
| Forward PE | n/a |
| Dividend | 2.55 (3.28%) |
| Ex-Dividend Date | Dec 27, 2024 |
| Volume | 751 |
| Open | 77.31 |
| Previous Close | 77.31 |
| Day's Range | 76.57 - 77.56 |
| 52-Week Range | 70.10 - 86.00 |
| Beta | 0.85 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 18, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
Medtronic continues losses for seven straight sessions
Medtronic (MDT) shares continue to decline, but analysts are still bullish on the stock despite concerns about the company's bottom line.
Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends
"Dividend Aristocrats
Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025
Medtronic PLC (MDT) Announces Third Quarter Cash Dividend for Fiscal Year 2025
Medtronic announces cash dividend for third quarter of fiscal year 2025
GALWAY, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal y...
Acutus Medical announces workforce reduction by 70%
Acutus Medical (AFIB) to reduce workforce by 70% and focus on supporting Medtronic products.
Price Over Earnings Overview: Medtronic
Looking into the current session, Medtronic Inc. (NYSE: MDT) shares are trading at $85.62, after a 1.06% decrease. Over the past month, the stock fell by 4.53% , but over the past year, it actually i...
Medtronic: Guidance Raised, Solid Dividend, Shares Still A Bargain
Best Long-Term Investment Stocks to Buy
Some of the best long-term investment stocks include companies that are in good financial standing, have a low valuation and pay consistent dividends.
Should You Pick Medtronic Stock At $85?
Medtronic (NYSE: MDT) reported its Q2 fiscal 2025 results (fiscal ends in April) last week, with revenues and earnings exceeding the street estimates. The company reported revenue of $8.4 billion and ...
The Best Large-Cap Stocks to Buy
Large-cap stocks are key additions to any well-rounded portfolio, but how do you find the best ones? We take a closer look here.
Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page . Stifel ra...
Medtronic receives FDA clearance for new InPen app
Medtronic receives FDA clearance for new InPen app with missed meal dose detection, preparing for Smart MDI system launch with Simplera CGM.
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland , Nov. 20, 202...
Medtronic's Q2 Performance: Highlights and Challenges
Medtronic's Q2 Performance: Highlights and Challenges
Medtronic (MDT) Q2 2025 Earnings Call Transcript
MDT earnings call for the period ending September 30, 2024.
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.
Gold Moves Higher; Medtronic Posts Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining by around 1% on Tuesday. The Dow traded down 0.03% to 43,374.79 while the NASDAQ rose 1.03% to 18,985.21. The S&P ...
Gold Moves Higher; Medtronic Posts Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining by around 1% on Tuesday.
Medtronic Q2 Earnings: Diabetes And Neuroscience Revenue Boost Growth, Raises Annual Outlook
Tuesday, Medtronic Plc (NYSE: MDT) reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion . The medical device maker reported adjusted EPS of $1.26, beating the c...
Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know
Medtronic's Stock Dips Despite Innovation Surge: What Investors Need to Know
Medtronic plc (MDT) Q2 2025 Earnings Call Transcript
MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results
Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025. Second-quarter earnings, excluding special items, rose 1% year...
Medtronic Beats And Raises, But Shares Flirt With A Sell Zone
Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in premarket trading.
Medtronic tightens FY25 guidance amid forex impact
Medtronic lifts annual profit view on strong demand for medical devices
Medtronic lifted the lower end of its annual profit forecast for a second time, banking on sustained demand for its medical devices in the U.S. and sending its shares up nearly 2% in premarket trading...